A Phase 3 Study of NE3107 in Probable Alzheimer's Disease

Clinical trial NCT04669028 · COMPLETED

Trial details

NCT number: NCT04669028
Sponsor: BioVie Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-08-05
Primary completion: 2023-09-30
Enrollment: 439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.